Bedaquiline loaded lipid nanoparticles: a promising candidate for TB treatment
Jary D., Hibbitts A., Lozano-Fernandez T., Pérez D., Lucia A., Ainsa J.A., Codony D., Freire C., Redinger N., Schaible U., Coya Raboso J.M., Tailleux L., Navarro F., CEA-LETI, FR
Increase in antibiotic resistance is a global concern worldwide[1], with 480,000 new cases of multi-drug resistant tuberculosis (MDR-TB) diagnosed each year. Therefore, the goals for the Nanotherapeutics for Antibiotic Resistant Emmerging Bacterial pathogens (NAREB) research [...]